|1.||Zwierz, Krzysztof: 6 articles (07/2013 - 01/2009)|
|2.||Waszkiewicz, Napoleon: 5 articles (07/2013 - 08/2009)|
|3.||Kępka, Alina: 3 articles (07/2013 - 01/2012)|
|4.||Szajda, Sławomir Dariusz: 3 articles (07/2013 - 01/2011)|
|5.||Páez de la Cadena, María: 3 articles (01/2013 - 10/2002)|
|6.||Lin, Chun-Hung: 2 articles (07/2015 - 08/2009)|
|7.||Kondagari, Gauthami Sudhamayee: 2 articles (01/2015 - 01/2011)|
|8.||Dubar, Faustine: 2 articles (07/2013 - 08/2012)|
|9.||Steenackers, Agata: 2 articles (07/2013 - 08/2012)|
|10.||Hottin, Audrey: 2 articles (07/2013 - 08/2012)|
|1.||Hepatocellular Carcinoma (Hepatoma)
12/15/1998 - "The data from this study suggest that cirrhotic patients who have a marked increase in serum alpha-L-fucosidase levels during follow-up should be closely monitored for signs of hepatocellular carcinoma development."
07/01/1989 - "[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]."
05/01/2014 - "Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis."
03/01/2012 - "Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma."
09/01/2004 - "Developing kinetic rate assay kit for alpha-L-fucosidase (AFU) by using a novel substrate 2-chloro-4-nitrophenyl-alpha-L-fucopyranoside (CNPF) and clinical implication in the diagnosis of hepatocellular carcinoma (HCC). "
|2.||Colonic Neoplasms (Colon Cancer)
10/01/2002 - "Thus, we suggest that differentiation of HT-29 colon cancer cells could be used as a model to study the alterations of the enzyme alpha-L-fucosidase during the progression of the tumoural process."
10/01/2002 - "Activity and properties of alpha-L-fucosidase are dependent on the state of enterocytic differentiation of HT-29 colon cancer cells."
01/01/2010 - "The higher AAL binding of beta-haptoglobin in colon cancer patients than in healthy subjects appeared to be due to alpha-L-fucosyl residue, since it was eliminated by bovine kidney alpha-fucosidase treatment. "
05/15/2012 - "In particular, fucosylation at Asn 241 of β-Hp in sera of colon cancer patients was clearly higher than in the other groups, and the ratio of fucosylated glycopeptides containing Asn 241 decreased greatly after treatment with α1-3/4 fucosidase. "
05/15/2012 - "Reactivity with fucosylated glycans was eliminated by treatment with α1-3/4 fucosidase but not α1-6 fucosidase, indicating that enhanced lectin reactivity with the fucose moiety of colon cancer β-Hp is due to Fucα1-3/4GlcNAc. "
05/01/2014 - "Alpha-L-fucosidase (AFU) has been proposed as a tumor marker for diagnosis of HCC in many studies. "
01/01/2013 - "In addition, activity and expression of alpha-L-fucosidase in selected matched tumor and healthy mucosa samples were analyzed. "
01/01/2000 - "The alpha-L-fucosidase activity was assayed in the tumor and in normal mucosa from each patient using a fluorometric method. "
12/01/1996 - "Serum alpha-L-fucosidase enzyme activity can be useful as a tumor marker in diagnosing advanced malignant epithelial ovarian tumors. "
12/01/1996 - "Patients with malignant ovarian tumors showed the lowest level of alpha-L-fucosidase activity in comparison to other malignant and benign tumors of the female genital tract and also in comparison to control group. "
03/01/2012 - "Alpha-l-fucosidase (AFU), a lysosomal enzyme present in all mammalian cells, has been proposed as a tumour marker since many studies reported increased AFU serum levels in patients with cirrhosis and HCC. "
08/01/1991 - "2. Mean serum alpha-L-fucosidase activity was significantly greater in 35 patients with hepatocellular carcinoma (225 +/- 69 nkat/l) than in 35 patients with cirrhosis and 20 normal subjects (134 +/- 30 and 93 +/- 28 nkat/l, respectively). "
12/15/1998 - "Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis."
06/01/1994 - "We found that the serum alpha-L-fucosidase activity level was significantly higher in 67 patients with hepatocellular carcinoma (695.1 +/- 245.5 nmol/ml/hr) than in 47 patients with cirrhosis (389.1 +/- 188.2 nmol/ml/hr; p < 0.001) and in 54 controls (202.0 +/- 104.6 nmol/ml/hr; p < 0.001). "
09/01/1992 - "The serum alpha-L-fucosidase activity level in patients with HCC (575.76 +/- 212.86 nmol/ml/h) was significantly higher than that found in patients with cirrhosis (274.55 +/- 138.97 nmol/ml/h; P less than 0.001) or other neoplasms (257.91 +/- 128.12 nmol/ml/h; P less than 0.001) and in controls (221.23 +/- 114.45 nmol/ml/h; P less than 0.001). "
03/01/2010 - "Understanding the role of alpha-L-fucosidase during human fertilization could lead to development of improved infertility treatments."
04/01/2013 - "These observations suggest that deficits in fucosidase protein and/or the presence of anti-fucosidase antibody may be responsible for some types of infertility."
09/01/1989 - "The glycosidase activities (beta-D-mannosidase, alpha-L-fucosidase and N-acetyl-beta-D-glucosaminidase) have been compared in whole and split ejaculate samples from men whose couple suffers from infertility. "
|7.||alpha-Glucosidases (Acid Maltase)
|1.||Enzyme Replacement Therapy